copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Sackler family | Brothers, OxyContin, Purdue Pharma, Opioid Epidemic . . . The Sackler family formerly owned the pharmaceutical company Purdue Pharma, known for developing the highly addictive drug OxyContin They gave up control of the company in 2025 as part of a settlement for their involvement in the opioid epidemic
Dilip Shanghvi | Biography Facts | Britannica Money The son of a wholesale drug distributor, Shanghvi launched Sun Pharma soon after graduating (1982) from the University of Calcutta with a bachelor’s degree in commerce
Pharmaceuticals, Vaccines, Facts - Britannica Money Like most “big pharma” companies, AstraZeneca’s future depends on its ability to: Maintain a pipeline of new and improved treatments in order to manage its revenue streams as patents for its key drugs expire The company has upped its R D spending in recent years, spending nearly $11 billion in 2023 on its pipeline of over 150 projects
Prescription Drug Costs - Encyclopedia Britannica Melissa Pistilli, “10 Top Pharma Companies by Revenue” (December 9, 2021), investingnews com Drug Discovery Development, “Pharma 50: The 50 Largest Pharmaceutical Companies in the World” (accessed March 30, 2022), drugdiscoverytrends com
Johnson Johnson | History, Products, Controversies | Britannica Money Johnson Johnson is the world’s second largest drug and biotechnology company by market capitalization, behind Eli Lilly (LLY) but ahead of other “big pharma” competitors such as AbbVie (ABBV), Novartis (NVS), and Merck (MRK)
The Opioid Crisis | Britannica Sackler family, American family, former owners of the pharmaceutical company Purdue Pharma Although the family is well known
McKinsey Company | Consulting Firm, Controversies, Facts - Britannica The company also worked with Purdue Pharma, the maker of OxyContin, throughout the opioid crisis Sales of the drug had been declining, so McKinsey wrote proposals with the goal to “turbocharge” its sales, ultimately making about $86 million for consulting for Purdue